Growth Metrics

Invivyd (IVVD) Assets Average (2021 - 2025)

Invivyd posted quarterly Assets Average of $208.0 million for Q4 2025, up 42.76% year-on-year from $145.7 million in Q4 2024, and up 82.24% on a QoQ basis from $114.1 million in Q3 2025.

Invivyd (IVVD) has 5 years of Assets Average data on file, last reported at $208.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 42.76% year-over-year to $208.0 million; the trailing twelve-month figure through Dec 2025 stood at $208.0 million (up 42.76% YoY), and the FY2025 full-year result was $203.2 million, up 13.3% from the prior year.
  • Assets Average for Q4 2025 stood at $208.0 million, up from $114.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $653.2 million in Q4 2021 and bottomed at $96.4 million in Q2 2025.
  • The 5-year median for Assets Average is $273.6 million (2023), against an average of $315.5 million.
  • Peak annual rise in Assets Average reached 42.76% in 2025, while the deepest fall reached 50.9% in 2025.
  • A 5-year view of Assets Average shows it stood at $653.2 million in 2021, then tumbled by 38.16% to $404.0 million in 2022, then tumbled by 37.6% to $252.0 million in 2023, then tumbled by 42.19% to $145.7 million in 2024, then soared by 42.76% to $208.0 million in 2025.
  • The last three Assets Average figures came in at $208.0 million (Q4 2025), $114.1 million (Q3 2025), and $96.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13.04 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 33.42 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.72 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 331.70 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 40.89 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 26.06 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 26.03 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 40.71 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 5.05 Bn
10 Invivyd 208.38 Mn -18.31 Mn - 208.02 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 208.02 Mn
Sep 30, 2025 114.15 Mn
Jun 30, 2025 96.44 Mn
Mar 31, 2025 116.63 Mn
Dec 31, 2024 145.72 Mn
Sep 30, 2024 169.63 Mn
Jun 30, 2024 196.41 Mn
Mar 31, 2024 222.32 Mn
Dec 31, 2023 252.05 Mn
Sep 30, 2023 295.17 Mn
Jun 30, 2023 332.99 Mn
Mar 31, 2023 366.87 Mn
Dec 31, 2022 403.96 Mn
Sep 30, 2022 454.68 Mn
Jun 30, 2022 520.44 Mn
Mar 31, 2022 588.18 Mn
Dec 31, 2021 653.18 Mn
Sep 30, 2021 542.13 Mn